Barclays
VCYT icon

Barclays’s Veracyte VCYT Stock Holding History

Barclays’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-10,000
Closed -$587K – 5733
2026
Q2 		$587K Buy
+10,000
New +$419K ﹤0.01% 3122

Other funds holding VCYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Barclays's VCYT Position: Q3 2026 in Review

Barclays increased its Veracyte (VCYT) stake by 345% in Q3 2026, buying an estimated $3.76M and bringing the position to 100,657 shares worth $4.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2084.

Barclays first reported a position in VCYT in Q4 2013 and has held it in 48 quarters since. The position peaked at $8.91M in Q4 2025. 201 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Barclays held 100,657 shares of Veracyte worth $4.63M as of Q3 2026.
  • Barclays bought 78,034 Veracyte shares in Q3 2026, an estimated $3.76M.
  • Veracyte made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2084 holding.
  • Barclays first reported a position in Veracyte in Q4 2013 and has held it in 48 quarters since.
  • Barclays's Veracyte position peaked at $8.91M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.